Pharmaron | Briefing, News, Analysis, Research, Data

Pharmaron

Pharmaron and is committed to helping partners succeed in drug discovery'

Pharmaron is a global pharmaceutical company, biotech company and research institute that provides fully integrated drug discovery, development and manufacturing CRMO solutions across the two stages of drug discovery and drug development, and is committed to helping partners succeed in drug discovery, development and commercialization.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jan 1, 2003

HQ location

Beijing, China

Legal name

Pharmaron Beijing Co., Ltd.

Website

http://www.pharmaron.com/

pharmaron@pharmaron-bj.com

Employees

1001-5000

All
News
Analysis
Research

Briefing Jun 24, 2022 10:39 AM · Healthcare | Technology | Industrials

The maximum payment limit of employee medical insurance in Shanghai in 2022 was raised to 590000 yuan

Briefing Jun 07, 2022 10:37 AM · Healthcare | Real Estate | Industrials

The port sector continued to strengthen and Guangzhou port rose by the daily limit

In-depth

Healthcare

Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital

The investors have a partiality for the projects which could meet clinical needs, possess cutting-edge innovation technology and a talented team.

Jun 27, 2022 12:24 PM

Briefing Apr 26, 2022 10:40 AM · Healthcare | Consumer Staples | Industrials

Runfeng shares: exchange rate changes have little impact on the company's performance

Briefing Apr 19, 2022 11:34 AM · Healthcare | Consumer Staples | Financials

The steel plate rose and Jinling mining rose by the limit

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Research

Technology, Healthcare, Consumer Staples

WIA2020 | Rising Tech Stars 2020: Global & China's 100

Dec 09, 2020 09:57 AM

Research

Healthcare

WIA2020 | Next 50 in Global Tech: Healthcare

Dec 09, 2020 09:39 AM

Research

Technology, Real Estate, Industrials

Tech for Global, Globalization Footprints of the Established and the New

May 29, 2020 08:30 PM

Briefing Mar 10, 2022 09:49 AM · Healthcare | Financials | Automotive

Traditional Chinese medicine stocks rose and strengthened, and Dali pharmaceutical touched the daily limit

Briefing Feb 25, 2022 10:38 AM · Technology | Financials | Healthcare

"Zhongke spectral light" completed tens of millions of yuan of round a financing

Briefing Feb 21, 2022 10:29 AM · Healthcare

Baidu responded that it was unable to search "referee document network": caused by misoperation of the technical team

Briefing Feb 16, 2022 01:29 PM · Healthcare | Consumer Staples | Automotive

According to the needs of epidemic prevention and control, the operation of Suzhou passenger transport line was suspended

Healthcare

NK Celltech Receives a Series A Round of Funding Worth More Than CNY 100 Million

NK Celltech recently received a Series A round of funding totaling more than CNY 100 million. Huagai Capital led this round of funding, which was followed by CASVC, Unifortune, 呈益资本, Sirius Capital, and QJ Capital.

Jul 01, 2022 03:58 PM

Healthcare

GCP ClinPlus Announces The Completion of A Funding Round Worth More Than CNY 100 Million

GCP ClinPlus has announced the completion of a CNY 100 million funding round. Tigermed (普瑞盛医药)led this round of financing, which was followed by 博荃百飞 and 杭州玖月创业投资.

Jul 01, 2022 02:18 PM

Briefing Feb 15, 2022 10:49 AM · Consumer Discretionary | Healthcare | Communication

The whole vehicle sector rose in shock, and Shuguang shares closed the limit

Briefing Feb 08, 2022 04:50 PM

GAC group: in January, the automobile sales volume was about 237200, with a year-on-year increase of 9.16%

Briefing Feb 08, 2022 09:39 AM · Healthcare | Consumer Staples | Financials

The digital currency sector opened sharply lower

Healthcare

Youwe Biotech Bags Nearly CNY 100 Mn in Series B Financing Round

Founded in 2017, Youwe Biotech, specializing in dissolving microneedle technology, will continue with the commercialization of its products with the fresh proceeds.

Jun 30, 2022 11:25 PM

Healthcare

Dialysis Provider Dakang Medical Raised CNY 400 Million Yuan in Series E Round.

This financing round was led by Ganjiang Kai Investment, a state-owned investment platform in Ganjiang, Jiangxi Province, and was followed by Central Enterprises Poor Regions Industry Investment Fund Co., and Neovision Capital.

Jun 30, 2022 04:16 PM

Briefing Jan 26, 2022 01:19 PM · Automotive | Healthcare | Consumer Staples

Kia's fourth quarter sales were 17.19 trillion won, lower than expected

Briefing Jan 25, 2022 07:30 PM · Technology | Automotive

GE's total revenue in the fourth quarter was $20.3 billion and is expected to be $21.4 billion.

Briefing Jan 25, 2022 05:40 PM · Consumer Staples | Technology

First environmental protection: it is proposed to issue renewable corporate bonds of no more than 6 billion yuan

Briefing Jan 21, 2022 07:29 PM · Healthcare | Technology | Financials

Jinyuan shares: Xu Gang, chairman of the board, plans to increase his holding of shares of no less than 15 million yuan

EqualOcean Analysis

EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.

Address

Beijing 9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China
Shanghai 2707-2708, AI Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York Suite 2967, 29th Floor, 4 World Trade 150 Greenwich St, New York, NY 10006

About